FINNENCE ▪ THE WIRE FILE
THE WIRE · № 69482
News▲ Bullish
Draper and Partners Awarded ARPA-H Funding to End Cold-Chain Dependence for Cell Therapies and Cancer Drugs

KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 16:15 UTC
LAST UPDATE2026-10-07 16:15 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
ARPA-H funding for cold-chain-free cell therapies could reduce logistics costs and expand biotech distribution.
Federal grant advances cell therapy distribution
CATALYST TO WATCH
Phase 1 milestones and follow-on funding
MAIN RISK
Early-stage program may not scale
FULL DISPATCH
CAMBRIDGE, Mass., Oct. 7, 2026 /PRNewswire/ -- Draper received up to $7.3 million other transaction award (OTA) from the Advanced Research Projects Agency for Health (ARPA-H) for Phase 1 of the agency's BioStabilization Systems (BoSS) program, which aims to develop new methods to produce,...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
←CORRELATIONshares Healthcare
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
←CORRELATIONshares Healthcare
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
←CORRELATIONshares Healthcare
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
←CORRELATIONshares Healthcare
Active Pharmaceutical Ingredients (API) Market worth $199.42 billion by 20312026-10-07 14:30 UTC
Active Pharmaceutical Ingredients (API) Market worth $199.42 billion by 20312026-10-07 14:30 UTC
←CORRELATIONshares Healthcare
Schizophrenia Market to Gain Momentum During the Forecast Period (2026-2036), with Growing Pipeline of Novel and Long-Acting Therapies2026-10-07 14:31 UTC
Schizophrenia Market to Gain Momentum During the Forecast Period (2026-2036), with Growing Pipeline of Novel and Long-Acting Therapies2026-10-07 14:31 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.